nifedipine has been researched along with schisandrol a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, AC; Chen, WC; Lu, CK; Ueng, YF; Wang, HJ | 1 |
| Chia-Hui Tan, E; Chiang, TY; Lee, IJ; Ueng, YF; Wang, HJ; Wang, YC; Yun, CH | 1 |
2 other study(ies) available for nifedipine and schisandrol a
| Article | Year |
|---|---|
Shenmai-Yin decreased the clearance of nifedipine in rats: The involvement of time-dependent inhibition of nifedipine oxidation.
Topics: Animals; Cyclooctanes; Cytochrome P-450 CYP3A; Drug Interactions; Drugs, Chinese Herbal; Humans; Lignans; Male; Nifedipine; Polycyclic Compounds; Rats; Rats, Sprague-Dawley | 2019 |
Effects of Shengmai San on key enzymes involved in hepatic and intestinal drug metabolism in rats.
Topics: Animals; Biomarkers; Cyclooctanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drugs, Chinese Herbal; Ginsenosides; Glucuronosyltransferase; Glutathione Transferase; Herb-Drug Interactions; Intestines; Lignans; Liver; Male; Microsomes; NAD(P)H Dehydrogenase (Quinone); Nifedipine; Oxidation-Reduction; Polycyclic Compounds; Rats, Sprague-Dawley; Saponins; Spirostans | 2021 |